Penghua Pharmaceutical Technology Stock Fund invests in stocks issued by listed companies in the pharmaceutical technology industry, accounting for no less than 80% of non-cash fund assets; Specifically, it includes traditional medicine fields (chemical pharmaceutical industry, traditional Chinese medicine industry, biological products industry, pharmaceutical business industry, medical equipment industry, health care industry, medical service industry, etc. ) and emerging medical fields. Penghua Pharmaceutical Science and Technology Stock Fund excavates high-quality listed companies through a combination of top-down and bottom-up, focuses on truly innovative companies, and introduces new technologies and models in emerging medical fields. At the same time, we will also consider companies with thematic opportunities and seize the opportunities of state-owned enterprise reform, mergers and acquisitions and other troubled times. Wind data shows that as of May 19, another medical theme fund managed by Liang Dongdong, the proposed fund manager of Penghua Medical Technology, has achieved a net growth rate of 97% since May/20 15, which has gained rich investment income for investors.